Quanterix Poised for $175 Million Acquisition of Akoya Bioscience: A Game-Changer in Precision Medicine

In a significant move that could reshape the landscape of precision medicine, Quanterix, a leading company in the field of diagnostic technology, is reportedly nearing an agreement to acquire Akoya Bioscience for an estimated $175 million. This acquisition reflects Quanterix's strategic intent to expand its capabilities and enhance its position in the biotech sector.

Continue reading